BioRegion Newsmakers | GenomeWeb

BioRegion Newsmakers

Premium

HCP Names Thomas Herzog as Executive Vice President/CFO as Mark Wallace Resigns

Thomas Herzog has been hired by publicly traded HCP as its executive vice president and chief financial officer effective May 1.

Herzog succeeds Mark Wallace, who held those positions as well as treasurer. Wallace will resign effective March 31, but "has agreed to serve in a consulting capacity until March 31, 2010, to assist in the transition" at the request of the board of directors, according to an HCP statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.